NEW YORK , July 08, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has been awarded a multi-year contract from the United States Department of Defense (DoD) to

NEW YORK , June 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez , Chief Executive Officer, will be a speaker at the Non-Conventional Threats

NEW YORK , June 11, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (Nasdaq: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M.

NEW YORK , June 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into an international promotion agreement with Meridian Medical Technologies, Inc.

Raw Materials expected to be used to Support Manufacture of 363,070 Courses of Oral TPOXX NEW YORK , May 20, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced the exercise of an

NEW YORK , Feb. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez , SIGA’s Chief Executive Officer, will present at the 8 th Annual SVB Leerink